A refined use of mutations to guide immunotherapy decisions
Nature
.
2022 Dec;612(7941):639-641.
doi: 10.1038/d41586-022-04448-z.
Authors
Chao Cheng
,
Christopher I Amos
PMID:
36536222
DOI:
10.1038/d41586-022-04448-z
No abstract available
Keywords:
Cancer; Medical research.
Publication types
News
Comment
MeSH terms
Humans
Immunotherapy*
Mutation
Neoplasms*
Grants and funding
R01 CA269764/CA/NCI NIH HHS/United States